Insider · CIK 0001517895

Patterson Albert

Reports to the SEC for 1 company · SCHAUMBURG, IL

sec.gov

Transactions

Companies

Filings

CIK

0001517895

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-03-19	Sagent Pharmaceuticals, Inc.F Tax Payment	EVP, Nat. Accts and Corp. Dev.	FTax Payment	−66 sh	$12.39	−$817.74	48,690
2016-02-25	Sagent Pharmaceuticals, Inc.F Tax Payment	EVP, Nat. Accts and Corp. Dev.	FTax Payment	−373 sh	$14.58	−$5,438.34	48,756
2016-02-22	Sagent Pharmaceuticals, Inc.F Tax Payment	EVP, Nat. Accts and Corp. Dev.	FTax Payment	−406 sh	$14.61	−$5,931.66	40,915
2016-02-22	Sagent Pharmaceuticals, Inc.A Award	EVP, Nat. Accts and Corp. Dev.	AAward	+8,214 sh	—	—	49,129
2016-02-22	Sagent Pharmaceuticals, Inc.Stock Option to BuyA Award	EVP, Nat. Accts and Corp. Dev.	AAward	+17.4K sh	—	—	17,391
2016-02-21	Sagent Pharmaceuticals, Inc.F Tax Payment	EVP, Nat. Accts and Corp. Dev.	FTax Payment	−637 sh	$14.61	−$9,306.57	41,321
2016-02-18	Sagent Pharmaceuticals, Inc.F Tax Payment	EVP, Nat. Accts and Corp. Dev.	FTax Payment	−452 sh	$15.16	−$6,852.32	41,958
2015-03-30	Sagent Pharmaceuticals, Inc.A Award	EVP, Nat. Accts and Corp. Dev.	AAward	+5,480 sh	—	—	42,410
2015-03-19	Sagent Pharmaceuticals, Inc.F Tax Payment	EVP, Nat. Accts and Corp. Dev.	FTax Payment	−66 sh	$27.32	−$1,803.12	36,930
2015-02-25	Sagent Pharmaceuticals, Inc.A Award	EVP, Nat. Accts and Corp. Dev.	AAward	+4,420 sh	—	—	36,996
2015-02-25	Sagent Pharmaceuticals, Inc.Stock Option to BuyA Award	EVP, Nat. Accts and Corp. Dev.	AAward	+8,208 sh	—	—	8,208
2015-02-22	Sagent Pharmaceuticals, Inc.F Tax Payment	EVP, Nat. Accts and Corp. Dev.	FTax Payment	−336 sh	$28.50	−$9,576	32,576
2015-02-21	Sagent Pharmaceuticals, Inc.F Tax Payment	EVP, Nat. Accts and Corp. Dev.	FTax Payment	−610 sh	$28.50	−$17.4K	32,912
2015-02-18	Sagent Pharmaceuticals, Inc.F Tax Payment	EVP, Nat. Accts and Corp. Dev.	FTax Payment	−452 sh	$27.22	−$12.3K	33,522
2014-03-19	Sagent Pharmaceuticals, Inc.A Award	EVP, Nat. Accts and Corp. Dev.	AAward	+841 sh	—	—	39,174
2014-03-19	Sagent Pharmaceuticals, Inc.Stock Option to BuyA Award	EVP, Nat. Accts and Corp. Dev.	AAward	+1,459 sh	—	—	1,459
2014-02-18	Sagent Pharmaceuticals, Inc.A Award	EVP, Nat. Accts and Corp. Dev.	AAward	+4,960 sh	—	—	38,333
2014-02-18	Sagent Pharmaceuticals, Inc.Stock Option to BuyA Award	EVP, Nat. Accts and Corp. Dev.	AAward	+8,865 sh	—	—	8,865
2013-02-22	Sagent Pharmaceuticals, Inc.F Tax Payment	EVP, Nat. Accts and Corp. Dev.	FTax Payment	−396 sh	$16.85	−$6,672.6	33,373
2013-02-21	Sagent Pharmaceuticals, Inc.A Award	EVP, Nat. Accts and Corp. Dev.	AAward	+6,991 sh	—	—	33,769
2013-02-21	Sagent Pharmaceuticals, Inc.Stock Option to BuyA Award	EVP, Nat. Accts and Corp. Dev.	AAward	+12.1K sh	—	—	12,067
2012-08-16	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Nat. Accts and Corp. Dev.	MExercise/Conversion	+638 sh	$4.31	+$2,749.78	11,467
2012-08-16	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Nat. Accts and Corp. Dev.	MExercise/Conversion	+2,552 sh	$4.23	+$10.8K	14,019
2012-08-16	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	EVP, Nat. Accts and Corp. Dev.	MExercise/Conversion	+12.8K sh	$4.31	+$55K	26,778
2012-08-16	Sagent Pharmaceuticals, Inc.Stock Option to BuyM Exercise/Conversion	EVP, Nat. Accts and Corp. Dev.	MExercise/Conversion	−638 sh	—	—	638
2012-08-16	Sagent Pharmaceuticals, Inc.Stock Option to BuyM Exercise/Conversion	EVP, Nat. Accts and Corp. Dev.	MExercise/Conversion	−2,552 sh	—	—	0
2012-08-16	Sagent Pharmaceuticals, Inc.Stock Option to BuyM Exercise/Conversion	EVP, Nat. Accts and Corp. Dev.	MExercise/Conversion	−12.8K sh	—	—	12,759
2012-02-22	Sagent Pharmaceuticals, Inc.A Award	EVP, Nat. Accts and Corp. Dev.	AAward	+4,450 sh	—	—	10,829
2012-02-22	Sagent Pharmaceuticals, Inc.Stock Option to BuyA Award	EVP, Nat. Accts and Corp. Dev.	AAward	+7,950 sh	—	—	7,950

Recent filings

Accepted (ET)
Mar 224
Sagent Pharmaceuticals, Inc.0001562180-16-002011
SEC(opens sec.gov)
Feb 254
Sagent Pharmaceuticals, Inc.0001562180-16-001815
SEC(opens sec.gov)
Feb 234
Sagent Pharmaceuticals, Inc.0001562180-16-001768
SEC(opens sec.gov)
Feb 224
Sagent Pharmaceuticals, Inc.0001562180-16-001728
SEC(opens sec.gov)
Apr 14
Sagent Pharmaceuticals, Inc.0001181431-15-005341
SEC(opens sec.gov)
Mar 194
Sagent Pharmaceuticals, Inc.0001181431-15-004872
SEC(opens sec.gov)
Feb 274
Sagent Pharmaceuticals, Inc.0001181431-15-003489
SEC(opens sec.gov)
Feb 244
Sagent Pharmaceuticals, Inc.0001181431-15-003275
SEC(opens sec.gov)
Feb 204
Sagent Pharmaceuticals, Inc.0001181431-15-002910
SEC(opens sec.gov)
Mar 214
Sagent Pharmaceuticals, Inc.0001181431-14-013614
SEC(opens sec.gov)
Feb 194
Sagent Pharmaceuticals, Inc.0001181431-14-007820
SEC(opens sec.gov)
Jan 24
Sagent Pharmaceuticals, Inc.0001181431-14-000148
SEC(opens sec.gov)
Feb 254
Patterson Albert0001181431-13-012526
SEC(opens sec.gov)

Companies

Sagent Pharmaceuticals, Inc.EVP, Nat. Accts and Corp. Dev.

Address

C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700

SCHAUMBURG, IL, 60195